Pulse Health partners with Tris Pharma to Power Omnichannel HCP Engagement for ADHD Products

Pulse Engagement Cloud and Tris Pharma to partner for smarter, centralized marketing intelligence across ADHD portfolio of products.

GARDEN CITY, N.Y., Aug. 6, 2025 /PRNewswire/ -- Pulse Health, a leading provider of marketing automation and engagement technology for the life sciences industry, announced today that Tris Pharma has onboarded as their strategic engagement platform partner for multiple ADHD products. The Pulse Engagement Cloud and Pulse Health's proprietary HCP data licensing solution unifies campaign efforts, improve marketing precision, and scale field and non-personal promotional outreach.

The partnership will support Tris Pharma's marketing strategy for its ADHD portfolio, enabling real-time campaign activation, behavior-based segmentation, and integrated analytics across all HCP interactions. Through Pulse's curated database of over 1 million opted-in healthcare professionals, Tris will be able to reach the right physician, with the right message, at the right time.

"We are excited to use the Pulse Platform to deepen our understanding of our ADHD HCPs, further enabling us to differentiate our products in a competitive marketplace," said Regie Simmons, Head of ADHD Marketing.

This partnership reflects a growing trend among pharmaceutical brands to adopt pharma-native platforms like the Pulse Engagement Cloud - offering deep pre-built integrations with life science technologies like Veeva, Medscape, Doceree, Sermo, and others - while also offering white-glove support to ensure seamless omnichannel deployment, onboarding, and performance measurement.

"We're thrilled to partner with Tris Pharma," said Ryan Alovis, CEO of Pulse Health. "Our platform is built for the life science industry from the ground up, with technology that delivers and a team that does the heavy lifting. We're proud to support Tris in driving meaningful results across their ADHD products."

With this addition to its client portfolio, Pulse Health continues its growth among forward-thinking biotech and pharma companies seeking to modernize their commercial operations, streamline omnichannel campaigns, and gain measurable business outcomes from non-personal promotion efforts.

About Pulse Health

Pulse Health is a leading provider of cloud-based non-personal promotional engagement software and services for the life sciences sector. Pulse Health's flagship product - the Pulse Engagement Cloud - offers a comprehensive suite of capabilities including marketing automation, advanced segmentation, omnichannel messaging, real-time analytics, and integration with top healthcare platforms. Pulse also offers solutions for HCP Data Licensing, Field Force Support, Email Creative Services, Sample Management, MCM Strategy, and more. With a reputation for innovation and best-in-class client service, Pulse Health empowers pharmaceutical brands to scale smarter and engage better.

About Tris Pharma

Tris Pharma is a privately held, innovation-driven biopharmaceutical company that is applying its drug development capabilities and proprietary technologies to transform the treatment of ADHD, pain, addiction and disorders of the central nervous system. Tris is an established commercial organization with a robust portfolio of best-in-class ADHD products and a promising pipeline of differentiated, near-term drug candidates. More information is available at www.trispharma.com and on LinkedIn @TrisPharma.

SOURCE Pulse Health